Álvaro
López Janeiro
Colaborador Clínico
University of California Los Angeles
Los Ángeles, Estados UnidosPublications in collaboration with researchers from University of California Los Angeles (1)
2023
-
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Nature Medicine, Vol. 29, Núm. 6, pp. 1370-1378